Search

Your search keyword '"Hellwig, Kerstin"' showing total 835 results

Search Constraints

Start Over You searched for: Author "Hellwig, Kerstin" Remove constraint Author: "Hellwig, Kerstin"
835 results on '"Hellwig, Kerstin"'

Search Results

1. Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

4. Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.

5. Childhood and adolescence factors and multiple sclerosis: results from the German National Cohort (NAKO)

6. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

8. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study

10. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis

11. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany – Baseline characteristics of the POWER@MS1 randomised controlled trial

15. Sex effects across the lifespan in women with multiple sclerosis

16. Multiple sclerosis progression: time for a new mechanism-driven framework

18. Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004)

27. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis

28. Restoring immune tolerance in neuromyelitis optica

29. Restoring immune tolerance in neuromyelitis optica

30. First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”

33. Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany – Baseline characteristics of the POWER@MS1 randomised controlled trial

35. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

39. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders

41. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

48. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

Catalog

Books, media, physical & digital resources